217 related articles for article (PubMed ID: 35477165)
41. Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.
Wang J; Zhang K; Grabowska D; Li A; Dong Y; Day R; Humphrey P; Lewis J; Kladney RD; Arbeit JM; Weber JD; Chung CH; Michel LS
Mol Cancer Res; 2011 Dec; 9(12):1686-95. PubMed ID: 21970857
[TBL] [Abstract][Full Text] [Related]
42. Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells.
Zhang L; Yang G; Zhang R; Dong L; Chen H; Bo J; Xue W; Huang Y
Int J Oncol; 2018 Aug; 53(2):515-526. PubMed ID: 29901071
[TBL] [Abstract][Full Text] [Related]
43. EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder.
Brunner A; Prelog M; Verdorfer I; Tzankov A; Mikuz G; Ensinger C
J Clin Pathol; 2008 Mar; 61(3):307-10. PubMed ID: 17586680
[TBL] [Abstract][Full Text] [Related]
44. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.
Sawanyawisuth K; Tantapotinan N; Wongkham C; Riggins GJ; Kraiklang R; Wongkham S; Puapairoj A
Ann Hepatol; 2016; 15(1):71-81. PubMed ID: 26626643
[TBL] [Abstract][Full Text] [Related]
45. TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy.
Hegedüs L; Okumus Ö; Mairinger F; Ploenes T; Reuter S; Schuler M; Welt A; Vega-Rubin-de-Celis S; Theegarten D; Bankfalvi A; Aigner C; Hegedüs B
Lung Cancer; 2023 Apr; 178():237-246. PubMed ID: 36907051
[TBL] [Abstract][Full Text] [Related]
46. Trophoblast Cell Surface Antigen 2 (Trop2) in Chromophobe Renal Cell Carcinoma.
Mikuteit M; Steffens S; Zschäbitz S; Autenrieth M; Weichert W; Hartmann A; Erlmeier F
Oncology; 2022; 100(6):331-336. PubMed ID: 35168242
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer.
Abbas M; Heitplatz B; Bernemann C; Boegemann M; Trautmann M; Schrader AJ; Wardelmann E; Schlack K
Oncol Lett; 2023 Dec; 26(6):527. PubMed ID: 38020299
[TBL] [Abstract][Full Text] [Related]
48. TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas.
Ning S; Liang N; Liu B; Chen X; Pang Q; Xin T
Neurol Sci; 2013 Oct; 34(10):1745-50. PubMed ID: 23397225
[TBL] [Abstract][Full Text] [Related]
49. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.
Cubas R; Zhang S; Li M; Chen C; Yao Q
Mol Cancer; 2010 Sep; 9():253. PubMed ID: 20858281
[TBL] [Abstract][Full Text] [Related]
50. Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors.
Viehweger F; Hoop J; Tinger LM; Bernreuther C; Büscheck F; Clauditz TS; Hinsch A; Jacobsen F; Luebke AM; Steurer S; Hube-Magg C; Kluth M; Marx AH; Krech T; Lebok P; Fraune C; Burandt E; Sauter G; Simon R; Minner S
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790919
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of TROP2 in human nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y
Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817
[TBL] [Abstract][Full Text] [Related]
52. PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases.
Davick JJ; Frierson HF; Smolkin M; Gru AA
Hum Pathol; 2018 Nov; 81():184-191. PubMed ID: 29969606
[TBL] [Abstract][Full Text] [Related]
53. TROP2 expression as prognostic marker for gastric carcinoma.
Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
[TBL] [Abstract][Full Text] [Related]
54. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
55. Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates.
Jabbarzadeh Kaboli P; Shabani S; Sharma S; Partovi Nasr M; Yamaguchi H; Hung MC
Am J Cancer Res; 2022; 12(4):1671-1685. PubMed ID: 35530278
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of TROP2 expression in colorectal cancer.
Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M
Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602
[TBL] [Abstract][Full Text] [Related]
57. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.
Dum D; Menz A; Völkel C; De Wispelaere N; Hinsch A; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T
Exp Mol Pathol; 2022 Jun; 126():104762. PubMed ID: 35390310
[TBL] [Abstract][Full Text] [Related]
58. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
Bruch PG; Plage H; Hofbauer S; Kornienko K; Weinberger S; Roßner F; Schallenberg S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Zecha H; Klatte T; Schlomm T; Horst D; Elezkurtaj S
Exp Mol Pathol; 2023 Jun; 131():104860. PubMed ID: 36997051
[TBL] [Abstract][Full Text] [Related]
59. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.
Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J
Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366
[TBL] [Abstract][Full Text] [Related]
60. Trop2: Jack of All Trades, Master of None.
Lenárt S; Lenárt P; Šmarda J; Remšík J; Souček K; Beneš P
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
